Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
BMC Infect Dis ; 21(1): 198, 2021 Feb 22.
Article in English | MEDLINE | ID: mdl-33618660

ABSTRACT

BACKGROUND: Elderly people in nursing homes are particularly vulnerable to COVID-19 due to their age, the presence of comorbidities, and community living. On March 14, 2020, at the beginning of the first epidemic wave of COVID-19 in France, a cluster was reported in a nursing home in the Nouvelle-Aquitaine region. We monitored the outbreak as well as the infection prevention and control (IPC) measures implemented. METHODS: A confirmed case was defined as laboratory-confirmed COVID-19 in a resident or staff member present in the nursing home between March 7 and May 1, 2020; and a probable case as a person presenting an acute respiratory illness after contact with a confirmed case. Symptomatic inpatient residents and symptomatic staff members were systematically tested for SARS-CoV-2. In addition, two screening sessions were held on site. RESULTS: We identified 109 cases (98 confirmed, 11 probable). The attack rate was 66% among residents and 45% among staff. Half of all cases were identified during the screening sessions. One-quarter of cases had minor symptoms or were asymptomatic. The case fatality rate among residents was 29%. IPC measures were rapidly implemented such as the quarantine of residents, the reinforcement of staff personal protective equipment, and home quarantine of staff testing positive, which were supplemented in April by systematic controls at the entrance of the nursing home and the creation of additional staff break rooms. CONCLUSIONS: This outbreak confirmed the considerable health impact of SARS-CoV-2 transmission in a nursing home. In addition to the implementation of IPC measures, the early detection of cases through the screening of residents and staff is essential to identify asymptomatic and pre-symptomatic cases and limit the spread of the virus.


Subject(s)
COVID-19/epidemiology , Disease Outbreaks , Nursing Homes , SARS-CoV-2 , Adult , Aged , Aged, 80 and over , COVID-19/prevention & control , Disease Outbreaks/prevention & control , Female , France/epidemiology , Humans , Male , Mass Screening , Middle Aged , Time Factors
4.
Cancer Radiother ; 16(5-6): 377-85, 2012 Sep.
Article in French | MEDLINE | ID: mdl-22921960

ABSTRACT

The aim of this study was to evaluate the impact of radiation therapy on sexual life. The analysis was based on a Pubmed literature review. The keywords used for this research were "sexual, radiation, oncology, and cancer". After a brief reminder on the anatomy and physiology, we explained the main complications of radiation oncology and their impact on sexual life. Preventive measures and therapeutic possibilities were discussed. Radiation therapy entails local, systematic and psychological after-effects. For women, vaginal stenosis and dyspareunia represent the most frequent side effects. For men, radiation therapy leads to erectile disorders for 25 to 75% of the patients. These complications have an echo often mattering on the patient quality of life of and on their sexual life post-treatment reconstruction. The knowledge of the indications and the various techniques of irradiation allow reducing its potential sexual morbidity. The information and the education of patients are essential, although often neglected. In conclusion, radiation therapy impacts in variable degrees on the sexual life of the patients. Currently, there are not enough preventive and therapeutic means. Patient information and the early screening of the sexual complications are at stake in the support of patients in the reconstruction of their sexual life.


Subject(s)
Radiotherapy/adverse effects , Sexual Dysfunction, Physiological/etiology , Sexual Dysfunctions, Psychological/etiology , Atrophy/etiology , Cervix Mucus/radiation effects , Constriction, Pathologic/etiology , Female , Fertility Preservation , Humans , Lubricants/therapeutic use , Male , Neoplasms/psychology , Neoplasms/radiotherapy , Phosphodiesterase 5 Inhibitors/therapeutic use , Quality of Life , Sexual Dysfunction, Physiological/therapy , Sexual Dysfunctions, Psychological/therapy , Vagina/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...